Article
Oncology
A. Hasenburg, D. Eichkorn, F. Vosshagen, E. Obermayr, A. Geroldinger, R. Zeillinger, M. Bossart
Summary: The study confirmed the accuracy of plasma CA125 as a tumor marker in ovarian cancer. By developing a formula combining CA125, HE4, OPN, leptin, and prolactin, successful prediction of malignant ovarian tumors was achieved. This formula showed high sensitivity and specificity in diagnosing malignant ovarian tumors.
Review
Chemistry, Medicinal
Yachana Mishra, Aditi Chattaraj, Vijay Mishra, Abhigyan Ranjan, Murtaza M. Tambuwala
Summary: Cancer is a deadly disease characterized by unregulated cell growth that can occur in any part of the body. Detecting ovarian cancer early can help lower the death rate, and aptamers have shown promise as probes for ovarian cancer detection. Compared to other probes, aptamers are more effective in targeting ovarian cancer. Several aptamers have been developed to detect the ovarian tumor marker VEGF, and this review discusses their potential for early-stage ovarian cancer detection and treatment efficacy.
Article
Reproductive Biology
Mahak Masoodi, Zafar A. Shah, Afaq H. Beigh, Sheikh Zahoor Ahmad, Abdul Wahid Mir, Besina Yasin, Roohi Rasool, Khalid Z. Masoodi, Gull Mohammad Bhat
Summary: This study found that serum Galectin-1 levels in ovarian cancer patients were associated with various variables, notably higher in postmenopausal patients and in epithelial ovarian tumors, with levels decreasing post-surgery and chemotherapy. Galectin-1 was shown to be a better biomarker than CA125 in distinguishing between normal, benign, malignant, and metastatic cases.
JOURNAL OF OVARIAN RESEARCH
(2021)
Article
Oncology
Chloe E. Barr, Kelechi Njoku, Gemma L. Owens, Emma J. Crosbie
Summary: This study evaluated the value of two simple, non-invasive urine biomarkers, CA125 and HE4, for the diagnosis of ovarian cancer in symptomatic women. The results showed that urine levels of CA125 and HE4 were significantly higher in women with ovarian cancer compared to controls. A combination of urine CA125 and HE4 had a similar sensitivity to serum CA125 in detecting ovarian cancer, suggesting their potential as non-invasive diagnostic tools.
Article
Critical Care Medicine
Fei Peng, Chenglong Liang, Wei Chang, Qin Sun, Jianfeng Xie, Haibo Qiu, Yi Yang
Summary: Elevated plasma HGF levels in sepsis patients are associated with poor prognosis and correlated with established markers of endothelial cell injury, indicating their potential as an efficient indicator for outcome prediction in septic patients.
JOURNAL OF INTENSIVE CARE MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Mariam Bagher, Oskar Rosmark, Linda Elowsson Rendin, Annika Nybom, Sebastian Wasserstrom, Catharina Muller, Xiao-Hong Zhou, Goran Dellgren, Oskar Hallgren, Leif Bjermer, Anna-Karin Larsson-Callerfelt, Gunilla Westergren-Thorsson
Summary: Mast cells and tryptase can increase the release of mediators from fibroblasts, influencing epithelial cell migration. Culture in scaffolds and co-culture with mast cells can promote VEGF release, while IL-6 decreases epithelial cell migration.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Materials Science, Biomaterials
G. Manasa, Ronald J. Mascarenhas, Nagaraj P. Shetti, Shweta J. Malode, Tejraj M. Aminabhavi
Summary: This article discusses biomarker research on ovarian cancer, with a focus on early detection and prevention of recurrence. Revisiting existing biomarkers to find effective predictors is crucial. Researching these biomarkers is essential for understanding the progression, diagnostics, and therapy of ovarian cancer.
ACS BIOMATERIALS SCIENCE & ENGINEERING
(2022)
Review
Chemistry, Medicinal
Jianqing Yu, George G. Chen, Paul B. S. Lai
Summary: Hepatocellular carcinoma is a major cause of cancer mortality worldwide, with current treatments showing unsatisfactory outcomes. The HGF/c-Met axis is considered crucial in regulating liver diseases and promoting HCC, and inhibiting this pathway may lead to the development of new and effective treatments for HCC.
MEDICINAL RESEARCH REVIEWS
(2021)
Article
Oncology
Pinelopi Kastana, Despoina Ntenekou, Eleni Mourkogianni, Michaela-Karina Enake, Athanasios Xanthopoulos, Effrosyni Choleva, Antonia Marazioti, Sophia Nikou, Racheal G. Akwii, Eleni Papadaki, Esther Gramage, Gonzalo Herradon, Georgios T. Stathopoulos, Constantinos M. Mikelis, Evangelia Papadimitriou
Summary: This study reveals the important role of PTPRZ1 in lung adenocarcinoma growth and angiogenesis. PTPRZ1 is expressed in endothelial cells and required for cell migration by VEGFA and PTN stimulation.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Article
Biochemistry & Molecular Biology
Yan Wang, Jiahui Ni, Aiyu Wang, Run Zhang, Linjie Wang
Summary: This study found that VEGFA regulates glycolipid metabolism in Schizothorax prenanti through AMPK alpha, contributing to a better understanding of the functions of VEGFA in fish glycolipid metabolism.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Multidisciplinary Sciences
Chong Fu, Yan Chen, Wei Xu, Yanping Zhang
Summary: Using genetic data, a Mendelian randomization analysis was conducted to explore the causal relationships between inflammatory cytokines and migraine. The results showed a positive association between hepatocyte growth factor (HGF) and migraine risk, while interleukin-2 (IL-2) was considered a downstream consequence of migraine.
SCIENTIFIC REPORTS
(2023)
Article
Multidisciplinary Sciences
Syamel Muhammad, Reyhan Julio Azwan, Rauza Sukma Rita, Restu Susanti, Yusrawati
Summary: This study investigates the predictive role of IL6, CA-125, and HE4 in tumor resectability in pre-operative patients with advanced epithelial ovarian cancer and finds a correlation between these markers and tumor resectability.
Article
Biochemistry & Molecular Biology
Myeongjoo Son, Bomi Ryu, Jun-Geon Je, You-Jin Jeon, Dae Yu Kim
Summary: This study found that microgravity stimulation changes the morphology of human retinal pigment epithelial cells and increases the expression of VEGF and EMT markers. Treatment with ishophloroglucin A (IPA) reduces VEGF production and EMT marker expression, restoring excessive cell migration in microgravity-stimulated cells. These findings suggest that IPA could be a potential therapeutic candidate for angiogenesis-related eye diseases.
Article
Reproductive Biology
Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng, Guiling Li, Changzhong Li, Huirong Shi, Yaqing Chen
Summary: This study evaluated the efficacy and safety of PLD in treating platinum-resistant and platinum-refractory relapse in patients with epithelial ovarian, fallopian tube, and peritoneal cancer. The results showed that PLD was associated with satisfactory efficacy, low frequency of adverse events, and high patient quality of life, with low baseline CA125 levels and a reduction in CA125 after the first cycle predicting satisfactory efficacy.
JOURNAL OF OVARIAN RESEARCH
(2021)
Article
Multidisciplinary Sciences
Yi Ding, Leticia Oliveira-Ferrer, Eike Vettorazzi, Karen Legler, Karin Milde-Langosch, Linn Woelber, Anna Jaeger, Katharina Prieske, Volkmar Mueller, Barbara Schmalfeldt, Sascha Kuerti
Summary: This study investigated the potential of vascular endothelial growth factor C (VEGF-C) in serum as a predictive biomarker for response to antiangiogenic therapy in ovarian cancer patients. The results showed that patients with higher levels of VEGF-C in serum had significantly increased chances of response to bevacizumab treatment. Therefore, VEGF-C serum level may serve as a useful biomarker for evaluating treatment response to bevacizumab.
Article
Oncology
Christina D. Drenberg, Jassada Buaboonnam, Shelley J. Orwick, Shuiying Hu, Lie Li, Yiping Fan, Anang A. Shelat, R. Kiplin Guy, Jeffrey Rubnitz, Sharyn D. Baker
CANCER CHEMOTHERAPY AND PHARMACOLOGY
(2016)
Article
Pharmacology & Pharmacy
C. D. Drenberg, S. W. Paugh, S. B. Pounds, L. Shi, S. J. Orwick, L. Li, S. Hu, A. A. Gibson, R. C. Ribeiro, J. E. Rubnitz, W. E. Evans, A. Sparreboom, S. D. Baker
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2016)
Article
Medicine, Research & Experimental
C. D. Drenberg, S. Hu, L. Li, D. R. Buelow, S. J. Orwick, A. A. Gibson, J. D. Schuetz, A. Sparreboom, S. D. Baker
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
(2016)
Letter
Oncology
Christina D. Drenberg, Daelynn R. Buelow, Stanley B. Pounds, Yong-Dong Wang, David Finkelstein, Richard J. Rahija, Sheila A. Shurtleff, Jeffrey E. Rubnitz, Hiroto Inaba, Tanja A. Gruber, Jeffery M. Klco, Sharyn D. Baker
LEUKEMIA & LYMPHOMA
(2017)
Article
Medicine, Research & Experimental
Jolieke G. van Oosterwijk, Daelynn R. Buelow, Christina D. Drenberg, Aksana Vasilyeva, Lie Li, Lei Shi, Yong-Dong Wang, David Finkelstein, Sheila A. Shurtleff, Laura J. Janke, Stanley Pounds, Jeffrey E. Rubnitz, Hiroto Inaba, Navjotsingh Pabla, Sharyn D. Baker
JOURNAL OF CLINICAL INVESTIGATION
(2018)
Article
Oncology
Kathleen I. Pishas, Christina D. Drenberg, Cenny Taslim, Emily R. Theisen, Kirsten M. Johnson, Ranajeet S. Saund, Ioana L. Pop, Brian D. Crompton, Elizabeth R. Lawlor, Franck Tirode, Jaume Mora, Olivier Delattre, Mary C. Beckerle, David F. Callen, Sunil Sharma, Stephen L. Lessnick
MOLECULAR CANCER THERAPEUTICS
(2018)
Editorial Material
Pharmacology & Pharmacy
C. D. Drenberg, S. D. Baker, A. Sparreboom
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2013)
Article
Genetics & Heredity
Linda Holmfeldt, Lei Wei, Ernesto Diaz-Flores, Michael Walsh, Jinghui Zhang, Li Ding, Debbie Payne-Turner, Michelle Churchman, Anna Andersson, Shann-Ching Chen, Kelly McCastlain, Jared Becksfort, Jing Ma, Gang Wu, Samir N. Patel, Susan L. Heatley, Letha A. Phillips, Guangchun Song, John Easton, Matthew Parker, Xiang Chen, Michael Rusch, Kristy Boggs, Bhavin Vadodaria, Erin Hedlund, Christina Drenberg, Sharyn Baker, Deqing Pei, Cheng Cheng, Robert Huether, Charles Lu, Robert S. Fulton, Lucinda L. Fulton, Yashodhan Tabib, David J. Dooling, Kerri Ochoa, Mark Minden, Ian D. Lewis, L. Bik To, Paula Marlton, Andrew W. Roberts, Gordana Raca, Wendy Stock, Geoffrey Neale, Hans G. Drexler, Ross A. Dickins, David W. Ellison, Sheila A. Shurtleff, Ching-Hon Pui, Raul C. Ribeiro, Meenakshi Devidas, Andrew J. Carroll, Nyla A. Heerema, Brent Wood, Michael J. Borowitz, Julie M. Gastier-Foster, Susana C. Raimondi, Elaine R. Mardis, Richard K. Wilson, James R. Downing, Stephen P. Hunger, Mignon L. Loh, Charles G. Mullighan
Article
Multidisciplinary Sciences
Chengzhi Xie, Christina Drenberg, Holly Edwards, J. Timothy Caldwell, Wei Chen, Hiroto Inaba, Xuelian Xu, Steven A. Buck, Jeffrey W. Taub, Sharyn D. Baker, Yubin Ge
Article
Cell Biology
Michaela Waibel, Vanessa S. Solomon, Deborah A. Knight, Rachael A. Ralli, Sang-Kyu Kim, Kellie-Marie Banks, Eva Vidacs, Clemence Virely, Keith C. S. Sia, Lauryn S. Bracken, Racquel Collins-Underwood, Christina Drenberg, Laura B. Ramsey, Sara C. Meyer, Megumi Takiguchi, Ross A. Dickins, Ross Levine, Jacques Ghysdael, Mark A. Dawson, Richard B. Lock, Charles G. Mullighan, Ricky W. Johnstone
Article
Multidisciplinary Sciences
Christina D. Drenberg, Anang Shelat, Jinjun Dang, Anitria Cotton, Shelley J. Orwick, Mengyu Li, Jae Yoon Jeon, Qiang Fu, Daelynn R. Buelow, Marissa Pioso, Shuiying Hu, Hiroto Inaba, Raul C. Ribeiro, Jeffrey E. Rubnitz, Tanja A. Gruber, R. Kiplin Guy, Sharyn D. Baker
NATURE COMMUNICATIONS
(2019)
Article
Oncology
Christina D. Drenberg, Alice A. Gibson, Stanley B. Pounds, Lei Shi, Dena P. Rhinehart, Lie Li, Shuiying Hu, Guoqing Du, Anne T. Nies, Matthias Schwab, Navjotsingh Pabla, William Blum, Tanja A. Gruber, Sharyn D. Baker, Alex Sparreboom
Article
Obstetrics & Gynecology
Christina D. Drenberg, Sandra Livingston, Ren Chen, Patricia A. Kruk, Santo V. Nicosia
OBSTETRICS AND GYNECOLOGY INTERNATIONAL
(2009)
Article
Oncology
Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L. Giuntoli II, Sarah H. Kim, Fiona Simpkins, Lainie Martin, Emily M. Ko
Summary: The prevalence of ERBB2 gene amplification was investigated among patients with gynecologic malignancies. The study found that ERBB2 amplification is frequently encountered in uterine serous carcinoma and mucinous ovarian carcinoma, but less common in endometrioid endometrial carcinoma.
GYNECOLOGIC ONCOLOGY
(2024)